495 related articles for article (PubMed ID: 18160990)
1. Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia.
Ziello JE; Jovin IS; Huang Y
Yale J Biol Med; 2007 Jun; 80(2):51-60. PubMed ID: 18160990
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the hypoxia-inducible factor in cancer and ischemic disease.
Brahimi-Horn MC; Pouysségur J
Biochem Pharmacol; 2007 Feb; 73(3):450-7. PubMed ID: 17101119
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor 1 in lower limb ischemia.
Ho TK; Abraham DJ; Black CM; Baker DM
Vascular; 2006; 14(6):321-7. PubMed ID: 17150152
[TBL] [Abstract][Full Text] [Related]
4. Life with oxygen.
Semenza GL
Science; 2007 Oct; 318(5847):62-4. PubMed ID: 17916722
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling.
Rey S; Semenza GL
Cardiovasc Res; 2010 May; 86(2):236-42. PubMed ID: 20164116
[TBL] [Abstract][Full Text] [Related]
6. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.
Shohet RV; Garcia JA
J Mol Med (Berl); 2007 Dec; 85(12):1309-15. PubMed ID: 18026917
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment.
Moon EJ; Sonveaux P; Porporato PE; Danhier P; Gallez B; Batinic-Haberle I; Nien YC; Schroeder T; Dewhirst MW
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20477-82. PubMed ID: 21059928
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications.
Westra J; Molema G; Kallenberg CG
Curr Med Chem; 2010; 17(3):254-63. PubMed ID: 20214567
[TBL] [Abstract][Full Text] [Related]
9. Cancer therapy by targeting hypoxia-inducible factor-1.
Li Y; Ye D
Curr Cancer Drug Targets; 2010 Nov; 10(7):782-96. PubMed ID: 20578983
[TBL] [Abstract][Full Text] [Related]
10. The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance.
Yin CL; Ma YJ
Curr Mol Pharmacol; 2024; 17():e18761429266116. PubMed ID: 38389420
[TBL] [Abstract][Full Text] [Related]
11. HIF-1: a key mediator in hypoxia.
Adams JM; Difazio LT; Rolandelli RH; Luján JJ; Haskó G; Csóka B; Selmeczy Z; Németh ZH
Acta Physiol Hung; 2009 Mar; 96(1):19-28. PubMed ID: 19264039
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
Burroughs SK; Kaluz S; Wang D; Wang K; Van Meir EG; Wang B
Future Med Chem; 2013 Apr; 5(5):553-72. PubMed ID: 23573973
[TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxia-inducible factor 1: mechanisms and consequences.
Semenza GL
Biochem Pharmacol; 2000 Jan; 59(1):47-53. PubMed ID: 10605934
[TBL] [Abstract][Full Text] [Related]
14. [Research progress of hypoxia-inducible factor 1 inhibitors against tumors].
Niu F; Li Y; Lai FF; Chen XG
Yao Xue Xue Bao; 2014 Jun; 49(6):832-6. PubMed ID: 25212028
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
[TBL] [Abstract][Full Text] [Related]
16. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological targeting of the HIF hydroxylases--A new field in medicine development.
Chan MC; Holt-Martyn JP; Schofield CJ; Ratcliffe PJ
Mol Aspects Med; 2016; 47-48():54-75. PubMed ID: 26791432
[TBL] [Abstract][Full Text] [Related]
18. HIF-1: hypoxia-inducible factor or dysoxia-inducible factor?
López-Lázaro M
FASEB J; 2006 May; 20(7):828-32. PubMed ID: 16675839
[TBL] [Abstract][Full Text] [Related]
19. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
Shi M; Guo XT; Shu MG; Chen FL; Li LW
Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
[TBL] [Abstract][Full Text] [Related]
20. Myeloid cell leukemia-1 (Mc1-1) is a candidate target gene of hypoxia-inducible factor-1 (HIF-1) in the testis.
Palladino MA; Shah A; Tyson R; Horvath J; Dugan C; Karpodinis M
Reprod Biol Endocrinol; 2012 Dec; 10():104. PubMed ID: 23216940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
